Lv21
146 积分 2024-01-31 加入
Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis
4小时前
待确认
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
28天前
已完结
Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target
1个月前
已完结
Early Aggressive Treatment Strategy against Myasthenia Gravis
1个月前
已完结
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
2个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2个月前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
3个月前
已完结
皖公网安备34019202002308
